AF
CRL icon

Allworth Financial’s Charles River Laboratories CRL Stock Holding History

Allworth Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.4K Sell
333
-67
-17% -$11.9K ﹤0.01% 2146
2026
Q1 		$68.9K Buy
400
+50
+14% +$9.27K ﹤0.01% 2093
2025
Q4 		$69.7K Buy
350
+133
+61% +$24.1K ﹤0.01% 1978
2025
Q3 		$33.9K Sell
217
-83
-28% -$13.2K ﹤0.01% 2380
2025
Q2 		$45.5K Buy
300
+190
+173% +$25.3K ﹤0.01% 2001
2025
Q1 		$12.7K Sell
110
-34
-24% -$5.7K ﹤0.01% 2317
2024
Q4 		$24.2K Sell
144
-12
-8% -$2.31K ﹤0.01% 1977
2024
Q3 		$30.7K Sell
156
-51
-25% -$10.6K ﹤0.01% 1645
2024
Q2 		$45.1K Buy
207
+84
+68% +$19K ﹤0.01% 1428
2024
Q1 		$33.3K Buy
123
+27
+28% +$6.45K ﹤0.01% 1486
2023
Q4 		$22.7K Buy
96
+29
+43% +$5.7K ﹤0.01% 1578
2023
Q3 		$13.1K Sell
67
-47
-41% -$9.65K ﹤0.01% 1741
2023
Q2 		$24K Buy
114
+78
+217% +$15.5K ﹤0.01% 1431
2023
Q1 		$7.27K Sell
36
-132
-79% -$29.9K ﹤0.01% 1896
2022
Q4 		$36.6K Buy
168
+63
+60% +$13.8K ﹤0.01% 1136
2022
Q3 		$21K Sell
105
-189
-64% -$40.8K ﹤0.01% 1270
2022
Q2 		$63K Buy
294
+14
+5% +$3.42K ﹤0.01% 830
2022
Q1 		$80K Sell
280
-70
-20% -$21.6K ﹤0.01% 777
2021
Q4 		$132K Buy
350
+10
+3% +$3.88K ﹤0.01% 624
2021
Q3 		$140K Buy
+340
New +$141K ﹤0.01% 554

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Allworth Financial's CRL Position: Q2 2026 in Review

Allworth Financial reduced its Charles River Laboratories (CRL) stake by 17% in Q2 2026, selling an estimated $11.9K and leaving 333 shares worth $75.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2146.

Allworth Financial first reported a position in CRL in Q3 2021 and has held it in 20 quarters since. The position peaked at $140K in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Allworth Financial held 333 shares of Charles River Laboratories worth $75.4K as of Q2 2026.
  • Allworth Financial sold 67 Charles River Laboratories shares in Q2 2026, an estimated $11.9K.
  • Charles River Laboratories made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2146 holding.
  • Allworth Financial first reported a position in Charles River Laboratories in Q3 2021 and has held it in 20 quarters since.
  • Allworth Financial's Charles River Laboratories position peaked at $140K in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.